CMS proposes changes to increase Medicaid drug price transparency
The Centers for Medicare & Medicaid Services this week proposed changes to the Medicaid Drug Rebate Program intended to improve manufacturer data integrity and help states verify drug prices. CMS will accept comments on the proposed rule through July 25.
Related News Articles
Headline
The AHA April 23 released a blog responding to a report issued April 22 by Paragon Health Institute. The blog highlights how the report relies on a long list…
Blog
In think‑tank reports, like the one released this week by Paragon Health Institute, hospitals are often reduced to abstractions — payment rates, charts,…
Headline
The Centers for Medicare and Medicaid Services April 8 issued guidance on implementing a provision within the reconciliation bill passed in July 2025 regarding…
Headline
The Centers for Medicare & Medicaid Services April 2 announced the release of new data on health care utilization and prices at the provider and service…
Headline
The Centers for Medicare & Medicaid Services Innovation Center March 24 announced the launch of a new model under Medicaid and the Children’s Health…
Headline
The Centers for Medicare & Medicaid Services March 11 issued guidance to state survey agency directors clarifying and reinforcing the roles and…